The rational design of an AIDS vaccine - PubMed

Affiliations

• PMID: 16497577
• DOI: 10.1016/j.cell.2006.02.005

Free article

The rational design of an AIDS vaccine

Daniel C Douek et al. Cell. 2006.

Free article

Abstract

The extraordinary genetic diversity and immune evasion of human immunodeficiency virus (HIV) pose significant challenges for vaccine development. AIDS vaccine design requires a scientifically driven, rational approach that encompasses the latest advances in viral molecular genetics, structural biology, and immunology.

Similar articles

• India targets local HIV strain in test of AIDS vaccine.

  Jayaraman KS. Jayaraman KS. Nature. 2004 Jan 15;427(6971):185. doi: 10.1038/427185b. Nature. 2004. PMID: 14724601 No abstract available.

• Is an effective HIV vaccine feasible?

  Cohen J. Cohen J. Science. 2005 Jul 1;309(5731):99. doi: 10.1126/science.309.5731.99. Science. 2005. PMID: 15994545 No abstract available.

• Progress toward an HIV vaccine.

  Letvin NL. Letvin NL. Annu Rev Med. 2005;56:213-23. doi: 10.1146/annurev.med.54.101601.152349. Annu Rev Med. 2005. PMID: 15660510 Review.

• Development of an AIDS vaccine: a daunting epidemiological challenge.

  Nathanson N, Mathieson BJ. Nathanson N, et al. Eur J Epidemiol. 2005;20(2):123-6. doi: 10.1007/s10654-004-6919-3. Eur J Epidemiol. 2005. PMID: 15792276 No abstract available.

• New hope for an AIDS vaccine.

  Robinson HL. Robinson HL. Nat Rev Immunol. 2002 Apr;2(4):239-50. doi: 10.1038/nri776. Nat Rev Immunol. 2002. PMID: 12001995 Review.

Cited by

• A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals.

  Walker LM, Simek MD, Priddy F, Gach JS, Wagner D, Zwick MB, Phogat SK, Poignard P, Burton DR. Walker LM, et al. PLoS Pathog. 2010 Aug 5;6(8):e1001028. doi: 10.1371/journal.ppat.1001028. PLoS Pathog. 2010. PMID: 20700449 Free PMC article.

• The use of genomics in microbial vaccine development.

  Bambini S, Rappuoli R. Bambini S, et al. Drug Discov Today. 2009 Mar;14(5-6):252-60. doi: 10.1016/j.drudis.2008.12.007. Epub 2009 Jan 15. Drug Discov Today. 2009. PMID: 19150507 Free PMC article. Review.

• Robust NK cell-mediated human immunodeficiency virus (HIV)-specific antibody-dependent responses in HIV-infected subjects.

  Stratov I, Chung A, Kent SJ. Stratov I, et al. J Virol. 2008 Jun;82(11):5450-9. doi: 10.1128/JVI.01952-07. Epub 2008 Mar 19. J Virol. 2008. PMID: 18353957 Free PMC article.

• Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins.

  Kothe DL, Decker JM, Li Y, Weng Z, Bibollet-Ruche F, Zammit KP, Salazar MG, Chen Y, Salazar-Gonzalez JF, Moldoveanu Z, Mestecky J, Gao F, Haynes BF, Shaw GM, Muldoon M, Korber BT, Hahn BH. Kothe DL, et al. Virology. 2007 Mar 30;360(1):218-34. doi: 10.1016/j.virol.2006.10.017. Epub 2006 Nov 13. Virology. 2007. PMID: 17097711 Free PMC article.

• Mucosal and systemic anti-HIV immunity controlled by A20 in mouse dendritic cells.

  Hong B, Song XT, Rollins L, Berry L, Huang XF, Chen SY. Hong B, et al. J Clin Invest. 2011 Feb;121(2):739-51. doi: 10.1172/JCI42656. Epub 2011 Jan 4. J Clin Invest. 2011. PMID: 21206085 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information